期刊文献+

复方丹参滴丸对药物代谢酶CYP1A2,NAT2和XO活性影响的研究 被引量:8

The Study on the Effect of Compound Danshen Dripping Pills on the Activity of CYP1A2,NAT2,and XO
原文传递
导出
摘要 目的探讨复方丹参滴丸对CYP1A2,NAT2和XO活性的影响,指导临床医师合理用药。方法以咖啡因作为探针药物,以HPLC测定受试者服用复方丹参滴丸前后尿液内咖啡因的5种主要代谢产物的相对含量,采用不同代谢物的比率分别评价CYP1A2,NAT2和XO活性的变化。结果受试者用药前CYP1A2,NAT2和XO平均活性为4.20±1.54,0.36±0.12,0.33±0.05;服用复方丹参滴丸14 d后三者的平均活性为4.26±1.95,0.32±0.12,0.32±0.07;服用复方丹参滴丸28 d后三者的平均活性为4.35±1.26,0.30±0.11,0.31±0.04;服药14 d后CYP1A2,NAT2和XO活性无统计学差异;服药28 d后CYP1A2和NAT2活性无统计学差异,但XO的平均活性降低,且具有统计学差异。结论复方丹参滴丸对药物代谢酶CYP1A2和NAT2活性无明显影响。服用治疗剂量的复方丹参滴丸对XO活性具有抑制作用。 OBJECTIVE To investigate the effect of compound danshen dripping pills on the activity of CYP1A2, NAT2 and XO and to forecast the drug-drug interaction with it, so as to instruct clinician to prescribe rationally. METHODS In thirty volunteers , two-way cross design was used, caffeine was used as a metabolic probe for CYP1A2,NAT2, and XO, before and after compound danshen dripping pills administration, urine samples were collected. The contents of five major metabolites of caffeine in the urine were determined by RP-HPLC method. And then the activity change of CYP1A2,NAT2 and XO was evaluated by the ratio of metabolites of caffeine . RESULTS It was found that the average activity of CYP1A2,NAT2 and XO were 4.20 ± 1.54,0.36 ± 0.12,0.33± 0.05 before treatment ,and 14 days after administration, the average activity of CYP1A2, NAT2 and XO were 4.26 ± 1.95,0.32 ± 0.12, 0.32 ±0.07, and 28 days after administration, the average activity of CYP1 A2 ,NAT2 and XO were 4.35 ± 1.26,0.30±0.11,0.31± 0.04. There was no statistical significance between before treatment and after taking medicine 14 days for CYP1A2,NAT2 and XO and also there was no statistical significance between before treatment and after taking medicine 28 days for CYP1A2 and NAT2. But there was statistical significance between before treatment and after taking medicine 28 days for XO. CONCLUSION Compound danshen dripping pills have no influence on CYPI A2 and NAT2, so compound danshen dripping pills do not modify the efficacy of drugs which metabolized by CYP1A2 and NAT2 taken simuhaneously. But compound danshen dripping pills may modify the efficacy of drugs which metabolized by XO taken simultaneously.
作者 吴慧 张霞
出处 《中国现代应用药学》 CAS CSCD 北大核心 2009年第1期8-11,共4页 Chinese Journal of Modern Applied Pharmacy
关键词 复方丹参滴丸 咖啡因 高效液相色谱法 CYP1A2 NAT2 XO compound danshen dripping pills caffeine HPLC eytochrome P450 1 A2 N-aeetyltransferase 2 xanthine oxidase
  • 相关文献

参考文献6

二级参考文献23

  • 1周宏灏.细胞色素氧化酶的个体和种族差异及其机理[A]..国内外药物代谢与药代动力学研究新进展研讨会资料汇编[C].,1998.79-110.
  • 2Tsuneo Ontura, Ryo Sato. The carbon monoxide - binding pigment of liver microsomes[ J ]. The Journal of Biological chemistry, 1964, 239(7) :2370.
  • 3SA Wardlaw, KJ Nikula, DA Kracko, et al . Effect of cigarette smoke on CYP1A1,1A2 and CYP2B1/2 of nasal mucosae in F344 rats[J].Carcinogenesis , 1998,19(4) :655.
  • 4Pratibha V Nerurkar, Sang S Park, Paul E Thomas, et al. Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytoehromes P450 1A2 and 2B, respectively, in the rat and mouse[J].Biochemical Pharmacology, 1993,46(5) :933.
  • 5Nobumitsu Haniaka, Hideto Jinno, Tetsuji Nishimura. Changes in cytochrome P450 enzymes by 1,1 - dichloroethylene in rat liver and kidney[J]. Arch Toxicol ,1997,72:9.
  • 6Silvia Menicagli, Annalisa Lippi, Marco Criscud. Effect of Rociverine on P450- dependent monoxygenases and its N-deetylation metabolism in rat liver microsomes[J]. Biochemical Pharmacology, 1993,45(5):1097.
  • 7Rendic S,Di Carlo FJ. Human cytochrome P450 enzymes: a status report summaizing their reactions substrates, inducers and inhibitors [ J ].Drug Metab Rev, 1997,29(2) :413.
  • 8何楠,欧阳冬生,朱冰,余帮宁.细胞色素P450药物氧化酶遗传药理学[A].见:周宏灏,主编.遗传药理学[M].第1版.北京:人民军医出版社,2003:65
  • 9Bendriss EK, Markoglou N, Wainer IW. Liquid chromatographic method for the simultaneous determination of caffeine and fourteen caffeine metabolites in urine [J]. J Chromatogr B, 2000;746:331 - 8
  • 10Notarianni LJ, Dobrocky P, Godlewski G, Jones RW, Bennett PN. Caffeine as a metabolic probe:NAT2 phenotyping[J]. Br J Clin Pharmacol, 1996;41:169

共引文献56

同被引文献2086

引证文献8

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部